#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary optic atrophy Small intestine leiomyosarcoma Red blood cell abnormality Congenital cystic kidney disease Congenital ectodermal dysplasia Eosinophilic granulomatosis with polyangiitis Immune-mediated renal disorder Erythema multiforme Cervix carcinoma recurrent Hyperphagia Prophylaxis against transplant rejection Desmoid tumour Thrombocytosis Penile cancer Marginal zone lymphoma refractory More trials…

    Learn about Rare Diseases

    Krabbe’s disease – Basic Information Skin angiosarcoma – Treatment Bronchopulmonary dysplasia – Diagnostics Hereditary angioedema Nodal marginal zone B-cell lymphoma – Diagnostics Synovial sarcoma recurrent – Diagnostics Fabry’s disease – Diagnostics Noonan syndrome – Trials in Disease Breast angiosarcoma – Life with Disease Splenic marginal zone lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gemcitabine Hydrochloride Omp72 Procarbazine Litifilimab ATUMELNANT Pyridoxine Hydrochloride X-396 Cetirizine Crizotinib Aclidinium Bromide Remimazolam Minocycline Hydrochloride Maridebart Cafraglutide Hydroxypropyl Cellulose Lf Atacicept Gsk4527226 Ribonucleic Acid K30 Ampicillin Sodium Water For Injection SRSD107 More therapies…

    Learn about Your Condition

    Vascular calcification Glomerulonephritis Myocardial infarction Tendon rupture Spondylolisthesis Kaposi's sarcoma Hand dermatitis Myocarditis Rheumatic disorder Diabetic autonomic neuropathy Epstein-Barr virus infection Post procedural hypotension BRAF gene mutation Alveolar bone defect Ligament operation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Papillary serous endometrial carcinoma

  • Study of Azenosertib (ZN-c3) for Women with Recurrent or Persistent Uterine Serous Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Papillary serous endometrial carcinoma
    Investigated Drugs:
    • Azenosertib
    • Granisetron
    • Netupitant
    France Italy Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!